63
Participants
Start Date
September 6, 2017
Primary Completion Date
May 22, 2019
Study Completion Date
June 30, 2020
Proxalutamide
Stage1:Dose esclation. Stage2:the expansion cohort where one or no DLT takes place in planned study cohort.
Beijing Cancer Hospital, Beijing
Sun-Yat-sen University Cancer center, Guangzhou
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Hunan Cancer Hospital, Changsha
Jiangsu Province Hospital, Nanjing
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
Tianjin Medical University Cancer Institute and Hospital, Tianjin
Peking University Cancer Hospital & Institute
OTHER
Tianjin Medical University Cancer Institute and Hospital
OTHER
Sun Yat-sen University
OTHER
Ruijin Hospital
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
Hebei Medical University Fourth Hospital
OTHER
Hunan Cancer Hospital
OTHER
Suzhou Kintor Pharmaceutical Inc,
INDUSTRY